Imipenem and Cilastatin
NDC 44567-705, Imipenem and Cilastatin, injection, powder, for solution, from WG Critical Care, LLC.
- Product NDC
- 44567-705
- Status
- Listed
- Labeler
- WG Critical Care, LLC
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207594
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/44567-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMIPENEM ANHYDROUS500 mg/1
- CILASTATIN SODIUM500 mg/1
Pharmacologic classes
Carbapenems [CS]; Dipeptidase Inhibitors [MoA]; Penem Antibacterial [EPC]; Renal Dehydropeptidase Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 44567-705-10 | 44567070510 | 10 VIAL in 1 CARTON (44567-705-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/46f54df9-5afe-430c-aa19-0d84c2044b0bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=44567-705
Use it
Look up 44567-705 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/44567-705 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 44567-705. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.